RT Journal Article
SR Electronic
T1 New drugs and preparations for open-angle glaucoma in adults
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 141
OP 144
DO 10.1136/dtb.2015.12.0372
VO 53
IS 12
YR 2015
UL http://dtb.bmj.com/content/53/12/141.abstract
AB Primary (or chronic) open-angle glaucoma (POAG or COAG) may be asymptomatic but causes progressive optic nerve damage with significant loss of visual field.1–3 Treatments aim to lower intraocular pressure (IOP) by reducing the production of aqueous humour and/or increasing its drainage.4,5 Here we update our previous articles1,4 to reflect new drugs, preservative-free preparations and fixed-dose drug combinations for POAG.